3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
80
Squamous Cell Carcinoma of Head and Neck
44
Lung Neoplasms
36
Urinary Bladder Neoplasms
22
Oropharyngeal Neoplasms
22
Head and Neck Neoplasms
19
Nasopharyngeal Carcinoma
18
Carcinoma
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
15
Biliary Tract Neoplasms
15
Small Cell Lung Carcinoma
14
Esophageal Squamous Cell Carcinoma
14
Uterine Cervical Neoplasms
13
Neoplasms
13
Neoplasm Metastasis
13
Cholangiocarcinoma
13
Ovarian Neoplasms
12
Colorectal Neoplasms
12
Pancreatic Neoplasms
11
Carcinoma, Squamous Cell
11
Laryngeal Neoplasms
10
Stomach Neoplasms
9
Mouth Neoplasms
9
Endometrial Neoplasms
9
Gallbladder Neoplasms
8
Carcinoma, Transitional Cell
8
Hypopharyngeal Neoplasms
7
Esophageal Neoplasms
7
Triple Negative Breast Neoplasms
6
Mesothelioma, Malignant
6
Interventions
durvalumab
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Cancer Unresectable
×
Cisplatin
×
90 days
×
Clear all
NCT06591650
2026-05-14
GCND
Fudan University
Phase 2
Recruiting
33 enrolled